Results 171 to 180 of about 8,911,089 (208)
Some of the next articles are maybe not open access.

A paradigm shift for cardiovascular outcome evaluation in diabetes: Major adverse cardiovascular events (MACE) to major adverse vascular events (MAVE)

Diabetes & Metabolic Syndrome: Clinical Research & Reviews, 2023
Drugs for diabetes are required to demonstrate cardiovascular safety through CV outcome trials (CVOT). The pre-defined end-points for cardiovascular outcome studies may not be sufficient to capture all clinically relevant atherosclerotic cardio vascular disease (ASCVD) events particularly peripheral arterial disease (PAD).We planned a scoping review ...
Ashu Rastogi   +3 more
openaire   +2 more sources

Prediction of Adverse Events in Patients Undergoing Major Cardiovascular Procedures

IEEE Journal of Biomedical and Health Informatics, 2017
Electronic health records (EHR) provide opportunities to leverage vast arrays of data to help prevent adverse events, improve patient outcomes, and reduce hospital costs. This paper develops a postoperative complications prediction system by extracting data from the EHR and creating features.
Bobak Mortazavi   +6 more
openaire   +2 more sources

Major Adverse Cardiovascular Events in Bulgarian Patients with Chronic Coronary Syndrome

Nigerian Journal of Clinical Practice, 2022
Background: In primary prevention, most guidelines rely on atherosclerotic cardiovascular disease risk assessment to determine the appropriateness and intensity of risk factor modification. Aims: This study aimed to analyze the prognostic role of risk factors, comorbidities, and ...
B, Stoimenov   +5 more
openaire   +2 more sources

Liraglutide for the prevention of major adverse cardiovascular events in diabetic patients

Expert Review of Cardiovascular Therapy, 2019
Introduction: The GLP-1 receptor agonist (GLP-1 RA) liraglutide has a half-life of approximately 13 h and is suitable for subcutaneous administration once daily. The use of liraglutide in people with type 2 diabetes has become popular because of the efficacy and durability in relation to glycemic control in combination with weight loss in most patients.
openaire   +3 more sources

Association Between Fluoroquinolones and Major Adverse Cardiovascular Events: A Systematic Review

Cardiology in Review
Fluoroquinolones (FQs) are routinely administered antibiotics that have demonstrated an increased propensity to cause major adverse cardiovascular events (MACE). We conducted a systematic review aimed to investigate the association between FQ usage and the risk of MACE.
Hritvik, Jain   +11 more
openaire   +2 more sources

Copeptin associates with major adverse cardiovascular events in patients on maintenance hemodialysis

Clinica Chimica Acta
End-stage renal disease (ESRD) necessitating hemodialysis pose substantial cardiovascular risks, with cardiovascular disease (CVD) as a leading cause of mortality. Biomarkers like copeptin have emerged as potential indicators of cardiovascular stress and prognosis in CKD populations.This study aimed to assess the prognostic value of copeptin in ...
Zhen Zhang   +9 more
openaire   +2 more sources

Echocardiography Predicts Major Adverse Cardiovascular Events after Renal Transplantation

Nephron Clinical Practice, 2014
<b><i>Introduction:</i></b> Cardiovascular disease is a leading cause of morbidity and mortality after renal transplantation. We analysed whether pre-transplant transthoracic echocardiograms (TTE) predicted major adverse cardiovascular events (MACE) after transplant.
Gu, Haotian   +5 more
openaire   +3 more sources

Major Adverse Cardiovascular Events and Prognosis in Patients With Coronary Slow Flow

Current Problems in Cardiology
This study aimed to investigate its clinical implications, risk factors, prognosis, and overall long-term outcomes. Demographic profiles, various clinical characteristics, and clinical outcomes were compared between 614 patients with coronary slow flow (CSF) and 428 patients with normal coronary artery.
Jiang Yu   +7 more
openaire   +2 more sources

Sex-Specific Trajectories of Arterial Stiffness and Major Adverse Cardiovascular Events

Hypertension
BACKGROUND: Sex-specific associations between brachial-ankle pulse wave velocity (baPWV) and major adverse cardiovascular events (MACE) remain unclear. Evidence for cardiovascular effects of longitudinal baPWV change is particularly lacking. METHODS:
Wanyue Wang   +9 more
openaire   +2 more sources

Major Adverse Cardiovascular Event (MACE)

2013
Riyad Khanfer   +73 more
openaire   +1 more source

Home - About - Disclaimer - Privacy